Hikma Pharmaceuticals Appoints Said Darwazah as CEO

LONDON, April 23 (Reuters) - London-listed Jordanian drugmaker Hikma Pharmaceuticals Plc (HIK.L: Quote, Profile , Research) said on Monday it had appointed Said Darwazah as chief executive officer with effect from July 1.

>>> Discuss This Story

MORE ON THIS TOPIC